I agree that this site is using cookies. You can find further informations here.
X
Kalland, Maria Elisabeth
40  results:
Search for persons X
?
1

Advancing rare disease treatment: EMA's decade-long insight..:

Kalland, Maria Elisabeth ; Pose-Boirazian, Tomas ; Palomo, Gloria Maria...
Gene Therapy.  31 (2024)  7-8 - p. 366-377 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Licensing of Orphan Medicinal Products—Use of Real-World Da..:

Naumann-Winter, Frauke ; Wolter, Franziska ; Hermes, Ulrike...
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Defining Satisfactory Methods of Treatment in Rare Diseases..:

Sheean, Maria E. ; Naumann-Winter, Frauke ; Capovilla, Giuseppe...
Frontiers in Medicine.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
4

The European Medicines Agency Review of Kymriah (Tisagenlec..:

Ali, Sahra ; Kjeken, Rune ; Niederlaender, Christiane...
The Oncologist.  25 (2019)  2 - p. e321-e327 , 2019
Link: https://doi.org/10.1634/..
 
?
5

Advancing rare disease treatment: EMA's decade-long insight..:

Kalland, Maria Elisabeth ; Pose-Boirazian, Tomas ; Palomo, Gloria Maria...
Sveučilište u Rijeci. Medicinski fakultet. Katedra za farmakologiju..  , 2024
Link: https://www.unirepositor..
 
?
6

Licensing of Orphan Medicinal Products—Use of Real-World Da..:

Naumann-Winter, Frauke ; Wolter, Franziska ; Hermes, Ulrike...
https://repository.publisso.de/resource/frl:6435164.  , 2022
Link: https://repository.publi..
 
?
7

Defining Satisfactory Methods of Treatment in Rare Diseases..:

Sheean, Maria E ; Naumann-Winter, Frauke ; Capovilla, Giuseppe...
info:eu-repo/semantics/altIdentifier/pmid/34513895.  , 2021
Link: https://hdl.handle.net/2..
 
?
8

Licensing of Orphan Medicinal Products—Use of Real-World Da..:

Frauke Naumann-Winter ; Franziska Wolter ; Ulrike Hermes...
https://www.frontiersin.org/articles/10.3389/fphar.2022.920336/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
9

Table1_Licensing of Orphan Medicinal Products—Use of Real-W..:

Frauke Naumann-Winter ; Franziska Wolter ; Ulrike Hermes...
doi:10.3389/fphar.2022.920336.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
10

Table1_Licensing of Orphan Medicinal Products—Use of Real-W..:

Frauke Naumann-Winter ; Franziska Wolter ; Ulrike Hermes...
doi:10.3389/fphar.2022.920336.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
11

Defining Satisfactory Methods of Treatment in Rare Diseases..:

Maria E. Sheean ; Frauke Naumann-Winter ; Giuseppe Capovilla...
https://www.frontiersin.org/articles/10.3389/fmed.2021.744625/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
12

Integrated Genomic Analysis of the 8q24 Amplification in En..:

Raeder, Maria B. ; Birkeland, Even ; Trovik, Jone...
PLoS ONE.  8 (2013)  2 - p. e54873 , 2013
Link: https://doi.org/10.1371/..
 
?
13

Aneuploidy related transcriptional changes in endometrial c..:

Klepsland Mauland, Karen ; Wik, Elisabeth ; Hoivik, Erling A....
Oncotarget.  8 (2016)  6 - p. 9696-9707 , 2016
Link: https://doi.org/10.18632..
 
?
14

Increased angiogenesis is associated with a 32-gene express..:

Stefansson, Ingunn M. ; Raeder, Maria ; Wik, Elisabeth...
Oncotarget.  6 (2015)  12 - p. 10634-10645 , 2015
Link: https://doi.org/10.18632..
 
?
15

Lipocalin 2 expression is associated with aggressive featur..:

Mannelqvist, Monica ; Stefansson, Ingunn M ; Wik, Elisabeth...
BMC Cancer.  12 (2012)  1 - p. , 2012
Link: https://doi.org/10.1186/..
 
1-15